ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 36 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $0 | -100.0% | 3,143 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 3,143 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 3,143 | -0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 3,144 | +14.3% | 0.00% | – |
| Q3 2019 | $1,000 | – | 2,751 | +31.4% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 2,094 | +0.1% | 0.00% | – |
| Q1 2019 | $1,000 | -66.7% | 2,092 | -18.6% | 0.00% | – |
| Q4 2018 | $3,000 | -66.7% | 2,569 | -40.6% | 0.00% | – |
| Q3 2018 | $9,000 | +80.0% | 4,324 | +74.9% | 0.00% | – |
| Q2 2018 | $5,000 | 0.0% | 2,472 | +7.1% | 0.00% | – |
| Q1 2018 | $5,000 | +25.0% | 2,308 | +15.4% | 0.00% | – |
| Q4 2017 | $4,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 12,079,080 | $27,178,000 | 0.29% |
| jvl associates llc | 58,500 | $132,000 | 0.13% |
| Sigma Planning Corp | 27,500 | $62,000 | 0.00% |
| NORTHWEST WEALTH MANAGEMENT, LLC | 280 | $1,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 4,158 | $9,000 | 0.00% |
| Ameritas Investment Partners, Inc. | 2,890 | $7,000 | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 60,388 | $136,000 | 0.00% |
| UBS Group AG | 9,495 | $21,000 | 0.00% |
| RHUMBLINE ADVISERS | 31,685 | $71,000 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1,290 | $2,902,000 | 0.00% |